Saturday, 9 March 2019

Implantable 'tea bag' in development releases insulin for children with diabetes

Children with Type 1 diabetes have only one option to control their blood sugar: insulin treatment. Ravaged by an autoimmune disease that attacks their own pancreas and islets—microscopic clusters of cells that sense blood sugar and produce insulin—patients are forced to rely on insulin from an external source.

* This article was originally published here